創薬市場におけるAI

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Technologies
2.3.1 Primary Technologies
2.3.2 Secondary Technologies
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global AI in Drug Discovery Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global AI in Drug Discovery Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global AI in Drug Discovery Market - Breakup by Offering
6.1 Software
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Attractive Investment Proposition by Offering

7 Global AI in Drug Discovery Market - Breakup by Application
7.1 Preclinical Testing
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Drug Optimization and Repurposing
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Target Identification
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Candidate Screening
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2025-2033)
7.5 Others
7.5.1 Historical and Current Market Trends (2019-2024)
7.5.2 Market Forecast (2025-2033)
7.6 Attractive Investment Proposition by Application

8 Global AI in Drug Discovery Market - Breakup by Therapeutic Area
8.1 Oncology
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Neurodegenerative Diseases
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2025-2033)
8.4 Metabolic Diseases
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2019-2024)
8.4.3 Market Segmentation
8.4.4 Market Forecast (2025-2033)
8.5 Others
8.5.2 Historical and Current Market Trends (2019-2024)
8.5.4 Market Forecast (2025-2033)
8.6 Attractive Investment Proposition by Therapeutic Area

9 Global AI in Drug Discovery Market - Breakup by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2025-2033)
9.2 Contract Research Organizations (CROs)
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2025-2033)
9.3 Research Centers and Academic Institutes
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2019-2024)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2025-2033)
9.4 Attractive Investment Proposition by End User

10 Global AI in Drug Discovery Market – Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Drivers
10.1.1.2 Historical and Current Market Trends (2019-2024)
10.1.1.3 Market Breakup by Offering
10.1.1.4 Market Breakup by Application
10.1.1.5 Market Breakup by Therapeutic Area
10.1.1.6 Market Breakup by End User
10.1.1.7 Key Players
10.1.1.8 Market Forecast (2025-2033)
10.1.2 Canada
10.1.2.1 Market Drivers
10.1.2.2 Historical and Current Market Trends (2019-2024)
10.1.2.3 Market Breakup by Offering
10.1.2.4 Market Breakup by Application
10.1.2.5 Market Breakup by Therapeutic Area
10.1.2.6 Market Breakup by End User
10.1.2.7 Key Players
10.1.2.8 Market Forecast (2025-2033)
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Drivers
10.2.1.2 Historical and Current Market Trends (2019-2024)
10.2.1.3 Market Breakup by Offering
10.2.1.4 Market Breakup by Application
10.2.1.5 Market Breakup by Therapeutic Area
10.2.1.6 Market Breakup by End User
10.2.1.7 Key Players
10.2.1.8 Market Forecast (2025-2033)
10.2.2 France
10.2.2.1 Market Drivers
10.2.2.2 Historical and Current Market Trends (2019-2024)
10.2.2.3 Market Breakup by Offering
10.2.2.4 Market Breakup by Application
10.2.2.5 Market Breakup by Therapeutic Area
10.2.2.6 Market Breakup by End User
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2025-2033)
10.2.3 United Kingdom
10.2.3.1 Market Drivers
10.2.3.2 Historical and Current Market Trends (2019-2024)
10.2.3.3 Market Breakup by Offering
10.2.3.4 Market Breakup by Application
10.2.3.5 Market Breakup by Therapeutic Area
10.2.2.6 Market Breakup by End User
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2025-2033)
10.2.4 Italy
10.2.4.1 Market Drivers
10.2.4.2 Historical and Current Market Trends (2019-2024)
10.2.4.3 Market Breakup by Offering
10.2.4.4 Market Breakup by Application
10.2.4.5 Market Breakup by Therapeutic Area
10.2.4.6 Market Breakup by End User
10.2.4.7 Key Players
10.2.4.8 Market Forecast (2025-2033)
10.2.5 Spain
10.2.5.1 Market Drivers
10.2.5.2 Historical and Current Market Trends (2019-2024)
10.2.5.3 Market Breakup by Offering
10.2.5.4 Market Breakup by Application
10.2.5.5 Market Breakup by Therapeutic Area
10.2.5.6 Market Breakup by End User
10.2.5.7 Key Players
10.2.5.8 Market Forecast (2025-2033)
10.2.6 Others
10.2.6.1 Historical and Current Market Trends (2019-2024)
10.2.6.2 Market Forecast (2025-2033)
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Drivers
10.3.1.2 Historical and Current Market Trends (2019-2024)
10.3.1.3 Market Breakup by Offering
10.3.1.4 Market Breakup by Application
10.3.1.5 Market Breakup by Therapeutic Area
10.3.1.6 Market Breakup by End User
10.3.1.7 Key Players
10.3.1.8 Market Forecast (2025-2033)
10.3.2 Japan
10.3.2.1 Market Drivers
10.3.2.2 Historical and Current Market Trends (2019-2024)
10.3.2.3 Market Breakup by Offering
10.3.2.4 Market Breakup by Application
10.3.2.5 Market Breakup by Therapeutic Area
10.3.2.6 Market Breakup by End User
10.3.2.7 Key Players
10.3.2.8 Market Forecast (2025-2033)
10.3.3 India
10.3.3.1 Market Drivers
10.3.3.2 Historical and Current Market Trends (2019-2024)
10.3.3.3 Market Breakup by Offering
10.3.3.4 Market Breakup by Application
10.3.3.5 Market Breakup by Therapeutic Area
10.3.3.6 Market Breakup by End User
10.3.3.7 Key Players
10.3.3.8 Market Forecast (2025-2033)
10.3.4 South Korea
10.3.4.1 Market Drivers
10.3.4.2 Historical and Current Market Trends (2019-2024)
10.3.4.3 Market Breakup by Offering
10.3.4.4 Market Breakup by Application
10.3.4.5 Market Breakup by Therapeutic Area
10.3.4.6 Market Breakup by End User
10.3.4.7 Key Players
10.3.4.8 Market Forecast (2025-2033)
10.3.5 Australia
10.3.5.1 Market Drivers
10.3.5.2 Historical and Current Market Trends (2019-2024)
10.3.5.3 Market Breakup by Offering
10.3.5.4 Market Breakup by Application
10.3.5.5 Market Breakup by Therapeutic Area
10.3.5.6 Market Breakup by End User
10.3.5.7 Key Players
10.3.5.8 Market Forecast (2025-2033)
10.3.6 Indonesia
10.3.6.1 Market Drivers
10.3.6.2 Historical and Current Market Trends (2019-2024)
10.3.6.3 Market Breakup by Offering
10.3.6.4 Market Breakup by Application
10.3.6.5 Market Breakup by Therapeutic Area
10.3.6.6 Market Breakup by End User
10.3.6.7 Key Players
10.3.6.8 Market Forecast (2025-2033)
10.3.7 Others
10.3.7.1 Historical and Current Market Trends (2019-2024)
10.3.7.2 Market Forecast (2025-2033)
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Drivers
10.4.1.2 Historical and Current Market Trends (2019-2024)
10.4.1.3 Market Breakup by Offering
10.4.1.4 Market Breakup by Application
10.4.1.5 Market Breakup by Therapeutic Area
10.4.1.6 Market Breakup by End User
10.4.1.7 Key Players
10.4.1.8 Market Forecast (2025-2033)
10.4.2 Mexico
10.4.2.1 Market Drivers
10.4.2.2 Historical and Current Market Trends (2019-2024)
10.4.2.3 Market Breakup by Offering
10.4.2.4 Market Breakup by Application
10.4.2.5 Market Breakup by Therapeutic Area
10.4.2.6 Market Breakup by End User
10.4.2.7 Key Players
10.4.2.8 Market Forecast (2025-2033)
10.5.3 Others
10.5.3.1 Historical and Current Market Trends (2019-2024)
10.5.3.2 Market Forecast (2025-2033)
10.6 Middle East and Africa
10.6.1 Market Drivers
10.6.2 Historical and Current Market Trends (2019-2024)
10.6.3 Market Breakup by Offering
10.6.4 Market Breakup by Application
10.6.5 Market Breakup by Therapeutic Area
10.6.6 Market Breakup by End User
10.6.7 Market Breakup by Country
10.6.8 Key Players
10.6.9 Market Forecast (2025-2033)
10.7 Attractive Investment Proposition by Region

11  Global AI in Drug Discovery Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Share by Key Players
11.4 Market Player Positioning
11.5 Top Winning Strategies
11.6 Competitive Dashboard
11.7 Company Evaluation Quadrant

12 Profiles of Key Players
12.1 Aria Pharmaceuticals Inc.
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 Financial    
12.1.5 SWOT Analysis                                          
12.1.6 Major News and Events
12.2 Atomwise Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies    
12.2.4 SWOT Analysis                                                      
12.2.5 Major News and Events
12.3 Benevolent AI
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis                                                  
12.3.5 Major News and Events
12.4 BioSymetrics Inc
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies    
12.4.4 SWOT Analysis                                                       
12.4.5 Major News and Events
12.5 BPGbio Inc
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
12.6 Deep Genomics
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Business Strategies
12.6.4 SWOT Analysis
12.6.5 Major News and Events
12.7 Envisagenics
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Business Strategies
12.7.4 SWOT Analysis
12.7.5 Major News and Events
12.8 Euretos
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Business Strategies
12.8.4 SWOT Analysis
12.8.5 Major News and Events
12.9 Evaxion Biotech A/S
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Business Strategies
12.9.4 SWOT Analysis
12.9.5 Major News and Events
12.10 Exscientia
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Business Strategies
12.10.4 SWOT Analysis
12.10.5 Major News and Events
12.11 Insilico Medicine
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Business Strategies
12.11.4 SWOT Analysis
12.11.5 Major News and Events
12.12 NVIDIA Corporation
12.12.1 Business Overview
12.12.2 Products Offered
12.12.3 Business Strategies
12.12.4 SWOT Analysis
12.12.5 Major News and Events
12.13 Okwin Inc
12.13.1 Business Overview
12.13.2 Products Offered
12.13.3 Business Strategies
12.13.4 SWOT Analysis
12.13.5 Major News and Events
12.14 XtalPi Inc
12.14.1 Business Overview
12.14.2 Products Offered
12.14.3 Business Strategies
12.14.4 SWOT Analysis
12.14.5 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

13 Global AI in Drug Discovery Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1    Overview
13.1.2    Drivers
13.1.3    Restraints
13.1.4    Opportunities
13.1.5    Impact Analysis
13.2   Porters Five Forces Analysis
13.2.1    Overview
13.2.2    Bargaining Power of Buyers
13.2.3    Bargaining Power of Suppliers
13.2.4    Degree of Competition
13.2.5    Threat of New Entrants
13.2.6    Threat of Substitutes
13.3 Value Chain Analysis

14 Strategic Recommendations

15 Appendix